PT778025E - Utilizacao de 8,9-di-hidroesterona na elaboracao de um medicamento para o tratamento de doencas provocadas por radicais livres - Google Patents

Utilizacao de 8,9-di-hidroesterona na elaboracao de um medicamento para o tratamento de doencas provocadas por radicais livres

Info

Publication number
PT778025E
PT778025E PT96308632T PT96308632T PT778025E PT 778025 E PT778025 E PT 778025E PT 96308632 T PT96308632 T PT 96308632T PT 96308632 T PT96308632 T PT 96308632T PT 778025 E PT778025 E PT 778025E
Authority
PT
Portugal
Prior art keywords
dihydroesterone
medication
development
treatment
free radicals
Prior art date
Application number
PT96308632T
Other languages
English (en)
Inventor
Steven Jay Adelman
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PT778025E publication Critical patent/PT778025E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
PT96308632T 1995-12-04 1996-11-28 Utilizacao de 8,9-di-hidroesterona na elaboracao de um medicamento para o tratamento de doencas provocadas por radicais livres PT778025E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US793195P 1995-12-04 1995-12-04

Publications (1)

Publication Number Publication Date
PT778025E true PT778025E (pt) 2004-08-31

Family

ID=21728885

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96308632T PT778025E (pt) 1995-12-04 1996-11-28 Utilizacao de 8,9-di-hidroesterona na elaboracao de um medicamento para o tratamento de doencas provocadas por radicais livres

Country Status (22)

Country Link
EP (1) EP0778025B1 (pt)
JP (1) JPH09169650A (pt)
KR (1) KR100444002B1 (pt)
CN (1) CN1104900C (pt)
AR (2) AR005866A1 (pt)
AT (1) ATE263565T1 (pt)
AU (1) AU703814B2 (pt)
BR (1) BR9605777A (pt)
CA (1) CA2191835A1 (pt)
CZ (1) CZ289780B6 (pt)
DE (1) DE69632117T2 (pt)
DK (1) DK0778025T3 (pt)
ES (1) ES2215187T3 (pt)
HU (1) HUP9603329A3 (pt)
IL (1) IL119744A (pt)
MX (1) MX9606009A (pt)
NO (1) NO312654B1 (pt)
NZ (1) NZ299858A (pt)
PT (1) PT778025E (pt)
SI (1) SI0778025T1 (pt)
SK (1) SK154296A3 (pt)
ZA (1) ZA969923B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19723794A1 (de) * 1997-06-06 1998-12-10 Jenapharm Gmbh Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität
JP2002322081A (ja) * 2001-02-22 2002-11-08 Nonogawa Shoji Kk 生体の遺伝子損傷抑制剤
BRPI0411103B1 (pt) 2003-06-09 2019-01-15 A Mcintyre John método, e, método de obtenção e isolamento de um autoanticorpo de um fluido biológico contendo anticorpo ou de um extrato de fluido biológico contendo anticorpo
US9557325B2 (en) 2003-06-09 2017-01-31 Redox-Reactive Reagents Llc Method of altering the binding specificity of proteins by oxidation-reduction reactions
US7892751B2 (en) 2003-06-09 2011-02-22 Redox-Reactive Reagents Llc Method of detecting or diagnosing of a neurodegenerative disease or condition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
DE4334823C2 (de) * 1993-10-09 1998-09-17 Schering Ag Verfahren zur Herstellung von Schwefelsäurehalbestern von Estrogenen
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
DE19509729A1 (de) * 1995-03-13 1996-09-19 Schering Ag 17-Difluormethylen-Estratriene

Also Published As

Publication number Publication date
AR059965A2 (es) 2008-05-14
NO312654B1 (no) 2002-06-17
HU9603329D0 (en) 1997-01-28
NO965165D0 (no) 1996-12-03
SI0778025T1 (en) 2004-08-31
JPH09169650A (ja) 1997-06-30
HUP9603329A2 (en) 1997-08-28
NO965165L (no) 1997-06-05
SK154296A3 (en) 1997-08-06
CA2191835A1 (en) 1997-06-05
HUP9603329A3 (en) 1998-01-28
HK1010095A1 (en) 1999-06-11
CN1158725A (zh) 1997-09-10
NZ299858A (en) 2001-03-30
DE69632117T2 (de) 2004-08-26
CZ353296A3 (en) 1997-08-13
MX9606009A (es) 1997-08-30
AU703814B2 (en) 1999-04-01
ATE263565T1 (de) 2004-04-15
EP0778025A1 (en) 1997-06-11
DK0778025T3 (da) 2004-06-07
KR100444002B1 (ko) 2004-11-03
BR9605777A (pt) 1998-08-25
IL119744A0 (en) 1997-03-18
ES2215187T3 (es) 2004-10-01
CN1104900C (zh) 2003-04-09
ZA969923B (en) 1998-05-26
DE69632117D1 (de) 2004-05-13
CZ289780B6 (cs) 2002-04-17
KR970032870A (ko) 1997-07-22
IL119744A (en) 2003-01-12
EP0778025B1 (en) 2004-04-07
AR005866A1 (es) 1999-07-21
AU7194496A (en) 1997-06-12

Similar Documents

Publication Publication Date Title
FI973868A7 (fi) D2-vitamiini- tai D4-vitamiinijohdannaisten käyttö sekundaarisen hyper paratyreoosin hoitoon tarkoitettu lääkkeen valmistuksessa
PT730864E (pt) Medicamento para tratar doencas inflamatorias cardiacas
DE69633645D1 (de) Vorrichtung zum Verabreichen von Medikamenten
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
BR9005093A (pt) Tampao,em especial para a higiene de senhoras,bem como processo e dispositivo para a fabricacao do mesmo
EE04156B1 (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
FI933770A7 (fi) Farmaseuttisia koostumuksia ihotautien hoitamiseen
KR970025636A (ko) 일회용 위생 마스크
BR9503812A (pt) Composto composição farmacêutica utilização método de tratamento de um ser humano processo para a preparação de um composto
FI946201L (fi) Itsestabiloidut oligonukleotidit terapeuttisina aineina
FI952721A7 (fi) Aine maksa-sappi-sairauksien hoitamiseksi
FI953915A0 (fi) Dupuytrenin taudin lievittämiseen
DE69403988D1 (de) Augenchirurgische Vorrichtung
NO995245L (no) Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for å behandle sykdommer som bevirker demyelinisering
DK0501705T3 (da) Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje
BR9610316A (pt) Composto processo para a produção e uso do mesmo processo para o tratamento de doença das vias aéreas e composição farmacêutica
DE69618560D1 (de) Medikament gegen ophthalmische erkrankungen
FI961378A0 (fi) Menetelmä N-metyyli-3-(1-metyyli-4-piperidinyyli)-14-indoli-5-etaanisulfonamidin valmistamiseksi
PH31643A (en) 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease.
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
PT866699E (pt) Utilizacao de inibidores de colinesterase para o fabrico de um medicamento para o tratamento de xerostomia
BR9608595A (pt) Utilização de n-cicloexil benzamidas para o tratamento de aglições intestinais
FI952953A7 (fi) Aineita metabolisten luustosairauksien hoitamiseen
BR9100431A (pt) Derivados de halogenoalilazolila,processo para sua fabricacao,aplicacao destes derivados,agente microbicida,processo para combater microorganismos,processo para a fabricacao de agentes microbicidas
SI0778025T1 (en) Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals